OBJECTIVE: To determine the efficacy of minocycline and rifampin-impregnated catheters compared to non-impregnated catheters in critically ill patients. DESIGN: Prospective, randomized, double-blind, controlled, multicenter trial. SETTING:Intensive care units of seven acute-care teaching hospitals in Spain. PATIENTS. Intensive care unit patients requiring triple-lumen central venous catheter for more than 3 days. INTERVENTIONS: At catheter insertion, 228 patients were randomized to minocycline and rifampin-impregnated catheters and 237 to non-impregnated catheters. Skin, catheter tip, subcutaneous segment, hub cultures, peripheral blood and infusate cultures were performed at catheter withdrawal. The rate of colonization, catheter-related bloodstream infection (CRBSI) and catheter-related clinical infectious complications (purulence at the insertion site or CRBSI) were assessed. MEASUREMENTS AND MAIN RESULTS: In the intention-to-treat analysis (primary analysis), the episodes per 1000 catheter days of clinical infectious complications decreased from 8.6 to 5.7 (RR =0.67, 95% CI 0.31-1.44), CRBSI from 5.9 to 3.1 (RR =0.53, 95% CI 0.2-1.44) and tip colonization from 24 to 10.4 (RR =0.43, 95% CI 0.26-0.73). Antimicrobial-impregnated catheters were associated with a significant decrease of coagulase-negative staphylococci colonization (RR =0.24, 95% CI 0.13-0.45) and a significant increase of Candida spp. colonization (RR =5.84, 95% CI 1.31-26.1). CONCLUSIONS: The use of antimicrobial-impregnated catheters was associated with a significantly lower rate of coagulase-negative staphylococci colonization and a significant increase in Candida spp. colonization, although a decrease in CRBSI, increase in 30-day survival or reduced length of stay was not observed.
RCT Entities:
OBJECTIVE: To determine the efficacy of minocycline and rifampin-impregnated catheters compared to non-impregnated catheters in critically illpatients. DESIGN: Prospective, randomized, double-blind, controlled, multicenter trial. SETTING: Intensive care units of seven acute-care teaching hospitals in Spain. PATIENTS. Intensive care unit patients requiring triple-lumen central venous catheter for more than 3 days. INTERVENTIONS: At catheter insertion, 228 patients were randomized to minocycline and rifampin-impregnated catheters and 237 to non-impregnated catheters. Skin, catheter tip, subcutaneous segment, hub cultures, peripheral blood and infusate cultures were performed at catheter withdrawal. The rate of colonization, catheter-related bloodstream infection (CRBSI) and catheter-related clinical infectious complications (purulence at the insertion site or CRBSI) were assessed. MEASUREMENTS AND MAIN RESULTS: In the intention-to-treat analysis (primary analysis), the episodes per 1000 catheter days of clinical infectious complications decreased from 8.6 to 5.7 (RR =0.67, 95% CI 0.31-1.44), CRBSI from 5.9 to 3.1 (RR =0.53, 95% CI 0.2-1.44) and tip colonization from 24 to 10.4 (RR =0.43, 95% CI 0.26-0.73). Antimicrobial-impregnated catheters were associated with a significant decrease of coagulase-negative staphylococci colonization (RR =0.24, 95% CI 0.13-0.45) and a significant increase of Candida spp. colonization (RR =5.84, 95% CI 1.31-26.1). CONCLUSIONS: The use of antimicrobial-impregnated catheters was associated with a significantly lower rate of coagulase-negative staphylococci colonization and a significant increase in Candida spp. colonization, although a decrease in CRBSI, increase in 30-day survival or reduced length of stay was not observed.
Authors: F C Tenover; R D Arbeit; R V Goering; P A Mickelsen; B E Murray; D H Persing; B Swaminathan Journal: J Clin Microbiol Date: 1995-09 Impact factor: 5.948
Authors: Cristóbal León; Francisco Alvarez-Lerma; Sergio Ruiz-Santana; Víctor González; María-Victoria de la Torre; Rafael Sierra; Miguel León; Juan-José Rodrigo Journal: Crit Care Med Date: 2003-05 Impact factor: 7.598
Authors: Marco Ranucci; Giuseppe Isgrò; Pier Paolo Giomarelli; Marco Pavesi; Aldo Luzzani; Iolter Cattabriga; Manuela Carli; Paolo Giomi; Antonio Compostella; Antonio Digito; Valerio Mangani; Vito Silvestri; Enzo Mondelli Journal: Crit Care Med Date: 2003-01 Impact factor: 7.598
Authors: Juan Alonso-Echanove; Jonathan R Edwards; Michael J Richards; Patrick Brennan; Richard A Venezia; Janet Keen; Vivian Ashline; Kathy Kirkland; Ellen Chou; Mark Hupert; Abigail V Veeder; Janice Speas; Judy Kaye; Kailash Sharma; Aliki Martin; V Dianne Moroz; Robert P Gaynes Journal: Infect Control Hosp Epidemiol Date: 2003-12 Impact factor: 3.254
Authors: K W Jauch; W Schregel; Z Stanga; S C Bischoff; P Brass; W Hartl; S Muehlebach; E Pscheidl; P Thul; O Volk Journal: Ger Med Sci Date: 2009-11-18
Authors: Nai Ming Lai; Nathorn Chaiyakunapruk; Nai An Lai; Elizabeth O'Riordan; Wilson Shu Cheng Pau; Sanjay Saint Journal: Cochrane Database Syst Rev Date: 2016-03-16
Authors: Aleksey Novikov; Manuel Y Lam; Leonard A Mermel; Anna L Casey; Tom S Elliott; Peter Nightingale Journal: Antimicrob Resist Infect Control Date: 2012-12-03 Impact factor: 4.887